AeronauticsAt the HEART OF LIFE SCIENCES, building tomorrow’s world
A business request?
ALTEN: the European consulting leader in the Life Sciences industry
ALTEN accompanies its clients in developing and manufacturing Life Sciences products focusing on 2 main business lines: Clinical Research Outsourcing (CRO) services and Life Sciences Manufacturing Operations (LSMO).
By leveraging a deep understanding of the sector’s complexities along with cutting-edge technological expertise, ALTEN has been instrumental in accelerating the development of innovative healthcare solutions. Our collaboration with leading pharmaceutical companies has led to the faster time-to-market of safe and effective medication. Our involvement in biomedical technology has facilitated the creation of advanced medical devices, improving patient outcomes and healthcare delivery. ALTEN’s commitment to excellence and innovation not only drives progress in the Life Sciences field but also exemplifies our role as a key partner for our customers.
ALTEN in the Life Sciences industry
331 M€
2024 turnover
+3,000
consultants
30
countries
6
areas of expertise
ARTICLES
Magazine Alt. 4 Life Sciences
Discover our new Alt. magazine on the subject of Life Sciences
HOT TOPICS IN THE LIFE SCIENCES INDUSTRY
Synergising disciplines for biotech innovations
Cross-disciplinary collaborations drive a broad spectrum of biotech innovations, accelerating medical advancements for safer, more precise treatments. Highlights include AI-powered CRISPR for gene editing, portable diagnostics through lab-on-a-chip technology, RNA therapies targeting HIV and cancer, bioprinting and tissue engineering for regenerative medicine, and stem cell applications broadening drug testing and disease models. Additionally, predictive modeling boosts drug development efficiency, while personalised medicine customises treatment based on genetic profiles. This collaborative ecosystem forecasts a trend towards strategic mergers and acquisitions, reflecting the impactful transformation of scientific discoveries into clinical and societal benefits.
Integrating emerging technologies into manufacturing
AI-enabled intelligent automation and advanced analytics are reshaping pharmaceutical manufacturing, making it agile, eco-friendly, and focused on patients’ needs. Real-time data and analytics allow for immediate operational decisions and improvements, addressing supply chain and talent shortages. Digital twins virtually simulate manufacturing facilities to optimise processes and enable predictive maintenance, reducing time-to-market for drugs. These advances support the shift from traditional batch methods to continuous manufacturing, further e nhancing efficiency while cutting waste. Meanwhile, flexible production technologies like single-use bioreactors, modular systems, and 3D printing are advancing personalised medicine by enabling the production of small, tailored drug batches.
Aligning regulations with technological advances
Regulatory evolutions underscore a global shift towards more adaptive and patient-centric regulatory frameworks, ensuring safety and efficacy in the face of technological advances. The European Union is debating reforms to tackle potential medicine shortages, fight antimicrobial resistance, and improve access to medicines. These discussions are also addressing supply disruptions under new medical device and in vitro diagnostics regulations. In the United States, the FDA is adapting guidelines for digital health and remote data collection, reflecting the sector’s shift towards innovative therapies and digital solutions. Additionally, standards like USP <665> are being introduced to ensure quality in pharmaceutical packaging amidst new material technologies.
our experts talking
“I am motivated in my work at ALTEN by the opportunity to help shape innovative solutions for the pharmaceutical industry and to contribute to improving patient care.”
Matthias
Senior Project Manager
“Despite some regulatory challenges, we believe that telemedicine, AI, and machine learning will fundamentally change the healthcare market. These technologies are key drivers of innovation for future medical devices and services – with a major impact on doctors and patients.”
René
Director of Sales Development
“Research and technological innovation are enabling increasingly personalized solutions. A future with great potential, which we at ALTEN are helping to shape every day.”
Dominic
Manager Sales Development
Interested in joining our journey?